small molecule

ETHINYL ESTRADIOL AND NORELGESTROMIN

ETHINYL ESTRADIOL; NORELGESTROMIN

Loss of exclusivity—loss of exclusivity
CompanyAmneal Pharmaceuticals →See this company's full patent-cliff portfolio

Drug detail

Brand nameETHINYL ESTRADIOL AND NORELGESTROMIN
Active ingredientETHINYL ESTRADIOL; NORELGESTROMIN
Strength0.035MG/24HR;0.15MG/24HR
Dosage formFILM, EXTENDED RELEASE
RouteTRANSDERMAL
ModalitySmall molecule
FDA approvalFebruary 2021
Marketing statusRX

Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the loss of exclusivity; estimates are projections, not legal advice.